Pyxis Oncology, Inc.
USD2.25
-0.11 (-4.66%)
CEO
Thomas Civik
IPO Date
2021-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.35
Prev. Close
$2.36
Day Low
$2.23
Day High
$2.42
52W Low
$0.97
52W High
$5.55
Market Cap
$0.14B
Volume
0.40M
| 4,900,039 |
| $3.29 |
| 2 Jul 2026 | Dupont Jakob | director | M-Exempt | Acquired | 35,000 | $1.60 |
| 2 Jul 2026 | Dupont Jakob | director | S-Sale | Disposed | 35,000 | $3.06 |
| 2 Jul 2026 | Dupont Jakob | director | M-Exempt | Disposed | 35,000 | $1.60 |
| 25 Mar 2026 | Dupont Jakob | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | Wadhane Jitendra | Prin Fin & Acct Officer | A-Award | Acquired | 109,461 | $0.00 |
| 25 Mar 2026 | Wadhane Jitendra | Prin Fin & Acct Officer | A-Award | Acquired | 262,635 | $1.36 |
| 25 Mar 2026 | FLAVIN JOHN L | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | Metzger Michael A | director | A-Award | Acquired | 45,867 | $1.36 |